PRESS RELEASES Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 218 Results August 5, 2019 Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates July 29, 2019 Minerva Neurosciences to Report Second Quarter 2019 Financial Results and Business Updates on August 5, 2019 June 24, 2019 Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia June 23, 2019 Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial With Seltorexant June 12, 2019 Minerva Neurosciences to Present at JMP Securities Life Sciences Conference May 29, 2019 Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019 May 13, 2019 Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs May 6, 2019 Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates April 29, 2019 Minerva Neurosciences to Report First Quarter 2019 Financial Results and Business Updates on May 6, 2019 April 11, 2019 Minerva Neurosciences Presents Pre-Clinical Data Suggesting a Mechanistic Role of Roluperidone in Addressing Negative Symptoms of Schizophrenia «...89101112...»